Barclays Initiates Coverage On Claritev with Overweight Rating, Announces Price Target of $28

Benzinga Newsdesk www.benzinga.com Positive 56.6%

Neg 0% Neu 0% Pos 56.6%

Barclays analyst Glen Santangelo initiates coverage on Claritev (NYSE:CTEV) with a Overweight rating and announces Price Target of $28.